KomiPharm Ranks High in Search... Stock Price Down 2.4%
As of 11:30 AM on the 26th, Komipharm is trading at 10,150 KRW, down 2.4% from the previous day. This represents a 15.77% decline compared to January 27. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners have net sold 37,789 shares of Komipharm, while institutions have net bought 1,000 shares, according to provisional data. Over the past five days, individual investors have net sold 83,014 shares, while foreigners and institutions have net bought 86,390 shares and net sold 8,287 shares, respectively.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Two Days Before Strike... Central Labor Relations Commission Chair Park Soogeun Says "Differences Narrowing... Possibility of Agreement"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
